Reference
US Food & Drug Administration (FDA). Adamis Pharmaceuticals Corporation Issues Nationwide Voluntary Recall of SYMJEPI (Epinephrine) Injection for Potential Manufacturing Defect. Internet Document : 22 Mar 2022. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/adamis-pharmaceuticals-corporation-issues-nationwide-voluntary-recall-symjepir-epinephrine-injection
Rights and permissions
About this article
Cite this article
Voluntary recall of SYMJEPI epinephrine injection in the US for potential manufacturing defect. Reactions Weekly 1900, 3 (2022). https://doi.org/10.1007/s40278-022-12355-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-12355-9